A Needle Technique for Achilles Tendon Lengthening in Pediatric Patients: A Prospective Study on Efficacy, Safety, and Feasibility
Launched by VESTRE VIKEN HOSPITAL TRUST · Apr 3, 2025
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new method for lengthening the Achilles tendon in children and teenagers who have a condition called equinus contracture, which can make walking difficult. The technique involves using a special needle to gently weaken the tendon, allowing it to be stretched to the right length over time. The study aims to include up to 50 participants aged 5 to 16 years who have issues like toe walking or tightness in the Achilles tendon. Parents or guardians will need to give their consent for their child to participate.
Participants in the trial will receive close follow-up care for one year after surgery, which will include regular check-ups by pediatric physiotherapists and ultrasound exams to monitor the tendon. The researchers want to ensure that this method is safe, effective, and easy to use, while also assessing how it affects the children's quality of life and satisfaction with their treatment. This is a great opportunity for eligible children facing challenges with walking to possibly benefit from a less invasive procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 5-16 years
- • Consent from parents/guardians
- * Indication for Achilles tendon lengthening (toe walking, spasticity), both unilateral and bilateral:
- • Equinus foot with dorsiflexion ≤ 0 degrees with the knee extended and the heel in neutral position.
- • Symptomatic equinus foot, meaning a foot position causing pain, discomfort, increased fatigue, etc.
- Exclusion Criteria:
- • Unwillingness to participate, lack of consent
- • Previous surgical Achilles tendon lengthening, e.g., for clubfoot
- • Received BoNT-a injection in the triceps surae within the last 6 months
- • Contracture in the ankle joint, i.e., equinus position not due to a tight Achilles tendon
- • Positive Silfverskiöld test and dorsiflexion \> 5 degrees with the knee extended (indicating the need for gastrocnemius recession)
- • Concurrent other surgery/other procedures on the same lower extremity, including BoNT-a injection
About Vestre Viken Hospital Trust
Vestre Viken Hospital Trust is a prominent healthcare institution in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a leading sponsor of clinical trials, Vestre Viken focuses on innovative healthcare solutions that enhance patient outcomes and contribute to scientific knowledge. The trust collaborates with various stakeholders, including academic institutions and industry partners, to facilitate rigorous research initiatives across multiple therapeutic areas. Committed to ethical standards and patient safety, Vestre Viken aims to foster an environment that promotes cutting-edge medical advancements and improves healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Drammen, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported